Original Articles 2012-02-20

The Use of Herbal Medicine and Traditional Medicine Formulations (TMFs) for Hypertension at Traditional Medicine Hospital, Yangon

This study was done to determine the use of herbal medicines and Traditional Medicine Formulations (TMFs) for treating hypertension at Outpatients' Department (OPD) of Traditional Medicine Hospital, Yangon. This study was a cross-sectional, descriptive study in 140 hypertensive patients attending th

Original Articles 2020-09-11

Is Community Intervention Effective for Improving Maternal, Newborn and Child Health Care in Hard-to-Reach Areas of Chin State, Myanmar?

To tackle the maternal, newborn and child health (MNCH) care needs is a challenging situation in remote and hard-to-reach areas. Intervention activities focusing on strengthening community health care network through community participation and supporting Basic Health Staffs for MNCH ser

Original Articles 2020-09-14

Incidence of Snakebite in Four Townships of Yangon Region

The true incidence of snakebite in Myanmar is unknown. The current data are based on hospital returns to Ministry of Health and Sports and they are likely to be under-reported. A community-based survey is useful to know the current burden of snakebite and thus for planning and formulating str

Next Prev

Aims of MHSR Journal

• To serve as an important medium for the publication of original research in the field of medical science and health research, thus filling gaps in health knowledge for effective utilization of research findings
• To impart current medical knowledge and updated scientific information obtained from research to health professionals for better and appropriate health care management
• To disseminate recent basic, applied and social research findings among health personnel of different strata for enhancing worldwide health development

Archives   2004

Myanmar   Health   Sciences   Research   Journal

Volume   16,  Number   1-3

TITLE:   Cross neutralization of cobra (N.Kaouthia) antivenom manufactured by Myanamr Pharmaceutical Factory with spitting cobra (N.mandalayensis) venom.
AUTHOR:   Aye Aye Myint; Tun Pe; Tin Zar Maw
SOURCE:   Myanmar Health Sciences Research Journal. 2004; 16(1-3): 11-13
ABSTRACT:   In 1998 a new species of spitting cobra (N. mandalayensis) was identified in mid-land, Myanmar by j.B. Slowinski. Myanmar Pharmaceutical Factory manufactures mono specific cobra (Naja kaouthia) antivenom for treating cobra bite cases. Venom ophthalmia following spitting of spitting cobra has been reported earlier. The objective of the study is to determine possibility of use of cobra antivenom in treating spitting cobra bite cases. In order to elucidat this fat, cross protective study of lethal effect of spitting cobra venom by cobra antivenom was assessed in rodents. Immunodiffusion was carried out between cobra antivenom will neutralise 3 LD50 i.v. spitting cobra venom. The cobra antivenom with cobra and spitting cobra venoms recognizes a similar number of preciptin bands. The study highlighted that cobra antivenom could be used to treat spitting cobra bite cases.
SUBJECT HEADINGS:   Snake Bites. Antivenins. Snake Venoms. Neutralization Tests. Cobra Venoms.
FULL TEXT: